FDA Product-Specific Guidance Revisions: ANDA Impact Matrix
A 2026 reference matrix mapping FDA product-specific guidance revisions to ANDA study stages: critical to editorial categories, the 21 August batch of 55 draft PSGs, a change register schema and a TWYNEO worked example.